Results 211 to 220 of about 1,256,081 (297)

Influenza hemagglutinin and neuraminidase membrane glycoproteins. [PDF]

J Biol Chem, 2010
Gamblin SJ, Skehel JJ.
europepmc   +1 more source

Glycolipids, glycoproteins and membrane fusion.

Indian journal of biochemistry & biophysics, 1988
openaire   +2 more sources

Interferon-induced transmembrane proteins in cancer and virus biology: a membrane perspective. [PDF]

mBio
Xia T, Cimarelli A.
europepmc   +1 more source

Antiviral activity of biogenic silver nanoparticles against HSV-1: integrating computational modeling and experimental validation. [PDF]

Iran J Microbiol
Soltani M, Elikaei A, Ghadam P, Ayadi Hassan S.   +3 more
europepmc   +1 more source

Current advances in the development of Nipah virus vaccines. [PDF]

Curr Res Microb Sci
Zhang X, Zheng J, He Q, Xu Y, Ji H, Jiang S, Zhang N.   +6 more
europepmc   +1 more source

Substrate Versatility of a Recombinant Bifidobacterial Endoglycosidase: <i>N</i>-Glycan Release and Profiling from Milk and Plant Glycoproteins. [PDF]

Int J Mol Sci
Duman H, Avcı İ, Salih B, Kayılı HM, Karav S.   +4 more
europepmc   +1 more source

Glycosylation disorders in pediatric epilepsy: pathophysiology, imaging and precision therapy. [PDF]

Front Neurol
Fan L, Shen Y, Wang J, Gan J.
europepmc   +1 more source

High-Throughput Proteomic and Glycoproteomic Analyses in Benign Prostatic Hyperplasia. [PDF]

J Am Soc Mass Spectrom
Wu F, Adrian AE, Zhao A, Zhang H, Liu PK, Lu Y, Strand DW, Ricke WA, Li L.   +8 more
europepmc   +1 more source

Identification of <i>Fasciola hepatica</i> gut-associated glycoproteins as potential vaccine candidates by lectin-affinity chromatography, flukicidal monoclonal antibodies, and affinity-enrichment mass spectrometry. [PDF]

Front Parasitol
Rechsteiner SG, Hasler S, Gehrig P, Deplazes P, Eichenberger RM.   +4 more
europepmc   +1 more source

Using Synthetic Glycans to Investigate Anti‐Glycan Antibodies and Explore Their Medical Potential

Angewandte Chemie International Edition, EarlyView.
Anti‐glycan antibodies are essential in health and disease. Access to novel glycan structures paves the way for progress in antibody profiling for biomarker discovery, antibody development, and vaccine design. We summarize the strategies to synthesize and utilize synthetic glycans for the development and application of anti‐glycan antibodies in basic ...
Fabienne Weber, Aina Valenti, Jiří Ledvinka, Oren Moscovitz, Peter H. Seeberger   +4 more
wiley   +1 more source